Tempest Therapeutics offers warrant inducement with 200% new warrant coverage

Tempest is inducing holders of November 2025 warrants to exercise for cash at $1.73/share, offering new warrants covering 200% of exercised shares. This capital raise mechanism allows the company to strengthen its balance sheet while providing warrant holders liquidity opportunities.